MDSpire - Takeaway
Feature

Diagnosis: Delayed – The Case for Faster Companion Diagnostic Delivery

From approvals and reimbursement to in-house testing and tissue stewardship - Jane Li discusses the barriers to precision diagnostics, and the route through them

Share

  • 1

    Companion diagnostics link patients to effective therapies.

  • 2

    Adoption of biomarker testing faces evidence and operational hurdles.

  • 3

    Academic centers lead in precision medicine; community settings lag.

  • 4

    Reimbursement poses a critical barrier.

  • 5

    Diagnostics companies must automate solutions for accessibility.

  • 6

    Pathologists play a crucial role in educating medical teams.

  • 7

    Integration of biomarker tests is essential for patient outcomes.

Original Source(s)

Diagnosis: Delayed – The Case for Faster Companion Diagnostic Delivery

  • by Helen Bristow

  • April 2, 2026

Related Content

Financial Hardship and Late-Stage Cancer Diagnosis

In a study reported in the Journal of Clinical Oncology, Khor et al found that prediagnosis financial hardship was associated with a diagnosis of cancer at later stages, particularly for cancers with ...

A New Route to Lymphoma Diagnosis

Liquid biopsy detects EBV-positive Burkitt’s cases with high specificity

  • April 2, 2026

  • 3 min
The Scent of an Ancient Mummy

Airborne chemical fingerprints uncover evolving preservation recipes and offer a non-destructive way to study ancient remains

  • April 2, 2026

  • 2 min